Gradual changes in research happen with steady investigation

Position yourself for the new type II diabetes research as part of the UTRELDA study.

The UTRELEDA study is evaluating an investigational drug for people living with type II diabetes. While in the study, participants will receive either the investigational drug or placebo and will attend a minimum of 15 study visits over a period of 52 weeks (12 months). The placebo looks just like the investigational drug but contains no active ingredients. Researchers use a placebo to better understand how an investigational drug works in participants.

To qualify for UTRELDA, you must:

Be at least 18 years of age

Have type II diabetes mellitus

Have a body mass index (BMI) of at least 27 kg/m2 (the study team can help determine this)

Been taking metformin for at least 90 days

Have an HbA1c between 7.0 and 10.5%, both inclusive

This is not a complete list of requirements to be in the study

There is no cost to participate.

You can make a difference!

Date of Birth (mm/dd/yyyy)

By signing up you agree to receive text messages and emails about this and similar studies near you. You can unsubscribe at any time. Text messages and data rates may apply. You also agree that StudyKIK may provide your personal information to the sponsor of this study or the research site to help determine if you qualify for this study. Please refer to StudyKIK's Privacy Policy and Terms of Service for more information.